239 related articles for article (PubMed ID: 10979858)
1. Immunology. Therapeutic manipulation of gut flora.
Shanahan F
Science; 2000 Aug; 289(5483):1311-2. PubMed ID: 10979858
[TBL] [Abstract][Full Text] [Related]
2. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
Steidler L; Hans W; Schotte L; Neirynck S; Obermeier F; Falk W; Fiers W; Remaut E
Science; 2000 Aug; 289(5483):1352-5. PubMed ID: 10958782
[TBL] [Abstract][Full Text] [Related]
3. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa.
Simčič S; Berlec A; Stopinšek S; Štrukelj B; Orel R
World J Microbiol Biotechnol; 2019 Feb; 35(3):45. PubMed ID: 30810891
[TBL] [Abstract][Full Text] [Related]
4. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model.
Umesaki Y; Setoyama H
Microbes Infect; 2000 Sep; 2(11):1343-51. PubMed ID: 11018451
[TBL] [Abstract][Full Text] [Related]
5. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
6. Delivery of therapeutic proteins through Lactococcus lactis.
Neirynck S; Steidler L
Biotechnol Genet Eng Rev; 2006; 22():253-66. PubMed ID: 18476334
[No Abstract] [Full Text] [Related]
7. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.
Rioux KP; Madsen KL; Fedorak RN
Gastroenterol Clin North Am; 2005 Sep; 34(3):465-82, ix. PubMed ID: 16084308
[No Abstract] [Full Text] [Related]
8. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells.
Souza BM; Preisser TM; Pereira VB; Zurita-Turk M; de Castro CP; da Cunha VP; de Oliveira RP; Gomes-Santos AC; de Faria AM; Machado DC; Chatel JM; Azevedo VA; Langella P; Miyoshi A
Microb Cell Fact; 2016 Aug; 15(1):150. PubMed ID: 27576902
[TBL] [Abstract][Full Text] [Related]
9. Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10.
Huyghebaert N; Vermeire A; Neirynck S; Steidler L; Remaut E; Remon JP
Eur J Pharm Biopharm; 2005 Aug; 60(3):349-59. PubMed ID: 15927456
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
Vanderpool C; Yan F; Polk DB
Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
[TBL] [Abstract][Full Text] [Related]
11. Microbes, intestinal inflammation and probiotics.
Khan MW; Kale AA; Bere P; Vajjala S; Gounaris E; Pakanati KC
Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):81-94. PubMed ID: 22149584
[TBL] [Abstract][Full Text] [Related]
12. Host-flora interactions in inflammatory bowel disease.
Shanahan F
Inflamm Bowel Dis; 2004 Feb; 10 Suppl 1():S16-24. PubMed ID: 15168825
[No Abstract] [Full Text] [Related]
13. Probiotics in inflammatory bowel disease: is it all gut flora modulation?
Ghosh S; van Heel D; Playford RJ
Gut; 2004 May; 53(5):620-2. PubMed ID: 15082574
[No Abstract] [Full Text] [Related]
14. Role of bacteria in experimental colitis.
Guarner F; Malagelada JR
Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):793-804. PubMed ID: 14507589
[TBL] [Abstract][Full Text] [Related]
15. Understanding why probiotic therapies can be effective in treating IBD.
Fedorak RN
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
[TBL] [Abstract][Full Text] [Related]
16. Transgenic probiotica as drug delivery systems: the golden bullet?
Yuvaraj S; Peppelenbosch MP; Bos NA
Expert Opin Drug Deliv; 2007 Jan; 4(1):1-3. PubMed ID: 17184157
[TBL] [Abstract][Full Text] [Related]
17. Actobiotics as a novel method for cytokine delivery.
Steidler L; Rottiers P; Coulie B
Ann N Y Acad Sci; 2009 Dec; 1182():135-45. PubMed ID: 20074282
[TBL] [Abstract][Full Text] [Related]
18. Germ therapy with IL-10 to treat inflammatory bowel diseases.
Michie C
Mol Med Today; 2000 Nov; 6(11):416. PubMed ID: 11074364
[No Abstract] [Full Text] [Related]
19. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
[TBL] [Abstract][Full Text] [Related]
20. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
